This site is intended for healthcare professionals
Drug news

Two Phase III trials show Tresiba (insulin degludec injection U-100) reduces hypoglycaemia versus insulin glargine U-100 in type 2 diabetes- Novo Nordisk

Read time: 1 mins
Last updated:13th Jun 2016
Published:13th Jun 2016
Source: Pharmawand
Register free for full access to medthority.com